Data / Form D filings / Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc.: Form D filings
Oric Pharmaceuticals, Inc., a biotechnology company in South San Francisco, CA, filed 3 Form D notices with the SEC between 2023 and 2025. The latest, on June 6, 2025, reports $125 million sold of a $125 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 240 E. GRAND AVE., 2ND FLOOR, South San Francisco, CA, 94080
- Phone
- (650) 388-5600
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1796280
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 6, 2025 | New notice | $125,000,000 | $125,000,000 | 15 | May 29, 2025 | sec.gov | |
| Jan 30, 2024 | New notice | $125,000,000 | $125,000,000 | 10 | Jan 23, 2024 | sec.gov | |
| Jul 5, 2023 | New notice | $84,999,678 | $84,999,678 | 12 | Jun 27, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Steve L. Hoerter | Director | |
| Lori L. Kunkel | Director | |
| Jacob M. Chacko | Executive Officer, Director | |
| Richard M. Heyman | Director | |
| Dominic M. Piscitelli | Executive Officer | |
| Angie L. You | Director | |
| Pratik M. Multani | Executive Officer | |
| Mardi C. Dier | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 2, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Oric Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.